CD40LG and COVID-19: Inaddition, this work uses recombinant IgG antibodies which are monomeric,with the possibility of manipulating the same variable region sequencesto create recombinant IgM type antibodies, decameric forms of whichmay improve capture and/or detector efficiency leading to more effectiverapid antigen assays for COVID-19 diagnosis.